HDL-C can suppress the release of pro-inflammatory mediators like tumor necrosis factor-α and interleukin-6 while enhancing superoxide dismutase activity to alleviate oxidative stress, delaying glomerulosclerosis and tubulointerstitial fibrosis [23]. Here, IL6 is linked to glomerulosclerosis.